Home | Bylvay® (odevixibat) - Patient site
Bylvay is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in: Patients 12 months of age and older with Alagille syndrome (ALGS) Patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC)
Learn about Bylvay® (odevixibat) Mechanism of Action – For HCPs
Learn more about the Bylvay (odevixibat) mechanism of action, with resources such as videos with full transcripts and diagrams. For US HCPs only.
Possible side effects in PFIC | Bylvay® (odevixibat) - Patient site
Bylvay safety information. Find information on possible side effects in people with progressive familial intrahepatic cholestasis (PFIC). See Safety and full Prescribing Information.
Bylvay® (odevixibat) clinical trials in Alagille syndrome - HCP
Explore efficacy data, the study design, and baseline characteristics for the ASSERT 1 and ASSERT 2 trials of Bylvay (odevixibat) in ALGS. For US HCPs only.
Understand Bylvay® (odevixibat) dosing and instructions – For HCPs
Learn more about Bylvay (odevixibat) dosing, including how to take Bylvay and recommended dosing for PFIC and ALGS. For US HCPs only.
How to take Bylvay for PFIC | Bylvay® (odevixibat) - Patient site
Bylvay is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in: Patients 12 months of age and older with Alagille syndrome (ALGS) Patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC)
Possible side effects in Alagille syndrome | Bylvay® (odevixibat ...
Bylvay is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in: Patients 12 months of age and older with Alagille syndrome (ALGS) Patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC)
DTC-Home | Bylvay
What is Bylvay? Bylvay is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in:
Alagille syndrome home | Bylvay® (odevixibat) - Patient site
Bylvay is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in: Patients 12 months of age and older with Alagille syndrome (ALGS) Patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC)
Itch results in Alagille syndrome | Bylvay® (odevixibat) - Patient site
Early and lasting reduction of itch with Bylvay. In a clinical trial of 52 people, Bylvay improved caregiver-reported scratching severity as early as week 4 and sustained over 24 weeks in people with Alagille syndrome.